simvastatin has been researched along with Angor Pectoris in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 16 (55.17) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassardjian, CD; Milone, M; Tian, X; Vladutiu, G; Wong, LJ | 1 |
| Ezekiel, TO; Hylton, AC | 1 |
| Hong, L; Lai, WY; Wu, SZ; Zhang, F; Zhang, L | 1 |
| Jonasson, L; Linderfalk, C; Olsson, AG; Schwartz, GG | 1 |
| George, A; Shakib, S | 1 |
| Arai, H; Matsuo, K; Miura, S; Nishikawa, H; Saku, K; Shimomura, H; Tsuchiya, Y; Zhang, B | 1 |
| Aukrust, P; Damås, JK; Frøland, SS; Gullestad, L; Haug, T; Semb, AG; Smith, C; Tunheim, SH; Waehre, T; Yndestad, A | 1 |
| Ahn, JY; Chung, WJ; Han, SH; Jin, DK; Kang, WC; Kim, DS; Kim, HS; Koh, KK; Seo, YH; Shin, EK; Son, JW | 1 |
| Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; Fox, KA; Gardner, LH; Lewis, EF; Mukherjee, R; Palmisano, J; Pedersen, TR; Pfeffer, MA; Ramsey, KE; Rouleau, JL; White, HD; Wiviott, SD | 1 |
| Fang, CH; Hui, RT; Li, JJ; Wang, C | 1 |
| Jiang, D; Li, L; Luo, Y; Wen, D; Yang, J | 1 |
| Dincer, I; Erol, C; Ertas, F; Ongun, A; Ozdol, C; Turhan, S | 1 |
| Bybee, KA; Duchonová, R; Homolová, I; Procházková, S; Tesar, D; Veselka, J | 1 |
| Budzyński, J; Fabisiak, J; Pułkowski, G; Suppan, K; Swiatkowski, M | 1 |
| Cakmak, M; Cakmak, N; Cetemen, S; Evrengul, H; Kuru, O; Tanriverdi, H | 1 |
| Berlion, AE; Morkel, H; Smedema, JP | 1 |
| Reynolds, T; Wierzbicki, A | 1 |
| Shepherd, J | 1 |
| Huttunen, J | 1 |
| Carotenuto, A; Carreras, G; de Divitiis, M; de Divitiis, O; Di Somma, S; Galderisi, M; Greco, V; Iannuzzo, G; Liguori, V; Montefusco, S; Rubba, P | 1 |
| Berg, K; Cook, TJ; Faergeman, O; Kjekshus, J; Miettinen, TA; Musliner, TA; Olsson, AG; Pedersen, T; Pyörälä, K | 1 |
| Gutzwiller, F; Lüscher, TF; Szucs, TD | 1 |
| Pedersen, TR | 1 |
| Baller, D; Gleichmann, U; Holzinger, J; Lehmann, J; Notohamiprodjo, G; Weise, R | 1 |
| Hashimoto, T; Hosokawa, R; Linxue, L; Miki, S; Nohara, R; Sasayama, S; Tamaki, S; Tanaka, M | 1 |
| de Jongh, S; Kastelein, JJ; Lansberg, PJ; Trip, MD | 1 |
| Auer, J; Eber, B | 1 |
3 review(s) available for simvastatin and Angor Pectoris
| Article | Year |
|---|---|
Choosing a drug from within a class.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Australia; Decision Making; Drug Costs; Drug Therapy, Combination; Drug Utilization; Drugs, Generic; Family Practice; Female; Humans; Hypertension; Indoles; Myocardial Infarction; Practice Patterns, Physicians'; Severity of Illness Index; Simvastatin | 2003 |
Statin therapy in clinical practice: new developments.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Enzyme Inhibitors; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Myocardial Infarction; Simvastatin | 1995 |
A clinical focus on statins.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Down-Regulation; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Multicenter Studies as Topic; Myocardial Infarction; Practice Guidelines as Topic; Pravastatin; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Simvastatin | 2001 |
14 trial(s) available for simvastatin and Angor Pectoris
| Article | Year |
|---|---|
[Effects of simvastatin on plasma SOD, MDA and 8-iso-PGF2α in patients with stable angina].
Topics: Aged; Angina Pectoris; Dinoprost; Female; Humans; Male; Malondialdehyde; Middle Aged; Simvastatin; Superoxide Dismutase | 2010 |
Are early clinical effects of cholesterol lowering mediated through effects on inflammation?
Topics: Angina Pectoris; Anticholesteremic Agents; Atorvastatin; Cholesterol; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrroles; Simvastatin; T-Lymphocytes | 2002 |
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
Topics: Angina Pectoris; Angina, Unstable; Atorvastatin; Coronary Artery Disease; Cross-Sectional Studies; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1; Leukocytes, Mononuclear; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Pyrroles; Simvastatin; Tumor Necrosis Factor-alpha | 2004 |
Simvastatin combined with ramipril treatment in hypercholesterolemic patients.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Chemokine CCL2; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Nitric Oxide; Plasminogen Activator Inhibitor 1; Ramipril; Simvastatin; Triglycerides; Vasodilation | 2004 |
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Ischemia; Proportional Hazards Models; Simvastatin; Treatment Outcome | 2004 |
Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin.
Topics: Acute Disease; Aged; Angina Pectoris; C-Reactive Protein; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Simvastatin; Single-Blind Method; Syndrome | 2004 |
[The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Disease; Exercise Test; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Simvastatin | 2005 |
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors; Simvastatin; Survival Analysis | 1994 |
Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Double-Blind Method; Ethics, Medical; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Scandinavian and Nordic Countries; Simvastatin; Time Factors | 1993 |
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia.
Topics: Analysis of Variance; Angina Pectoris; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Electrocardiography; Exercise Test; Forearm; Humans; Hypercholesterolemia; Lovastatin; Middle Aged; Regional Blood Flow; Simvastatin; Single-Blind Method | 1996 |
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
Topics: Adult; Aged; Aging; Angina Pectoris; Anticholesteremic Agents; Cohort Studies; Female; Hospitalization; Humans; Lipids; Male; Middle Aged; Mortality; Myocardial Infarction; Simvastatin; Survival Analysis | 1997 |
[Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions].
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cost Control; Cost-Benefit Analysis; Female; Forecasting; Health Care Costs; Health Services Misuse; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Scandinavian and Nordic Countries; Simvastatin; Survival Rate; Switzerland | 1997 |
Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Coronary Artery Disease; Coronary Circulation; Female; Hemodynamics; Humans; Lipids; Male; Middle Aged; Simvastatin; Time Factors; Tomography, Emission-Computed; Vasodilation | 1999 |
Effect of long-term cholesterol-lowering treatment with HMG-CoA reductase inhibitor (simvastatin) on myocardial perfusion evaluated by thallium-201 single photon emission computed tomography.
Topics: Angina Pectoris; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Simvastatin; Thallium; Tomography, Emission-Computed, Single-Photon | 2000 |
12 other study(ies) available for simvastatin and Angor Pectoris
| Article | Year |
|---|---|
Myopathy during treatment with the antianginal drug ranolazine.
Topics: Acetanilides; Angina Pectoris; Anticholesteremic Agents; Biopsy; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Middle Aged; Muscular Diseases; Piperazines; Ranolazine; Simvastatin; Treatment Outcome | 2014 |
Rhabdomyolysis in a patient receiving ranolazine and simvastatin.
Topics: Acetanilides; Angina Pectoris; Creatine Kinase; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Ranolazine; Rhabdomyolysis; Simvastatin | 2010 |
Statins induce the regression of left ventricular mass in patients with angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiomegaly; Case-Control Studies; Constriction, Pathologic; Drug Evaluation; Female; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Pravastatin; Retrospective Studies; Simvastatin | 2004 |
Effects of simvastatin on exercise-induced myocardial ischemia and plasma endothelin-1 concentrations in patients with stable angina.
Topics: Angina Pectoris; Endothelin-1; Exercise; Humans; Myocardial Ischemia; Placebos; Simvastatin | 2005 |
Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.
Topics: Angina Pectoris; Atorvastatin; Cholesterol, LDL; Collateral Circulation; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin | 2006 |
Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardium; Pilot Projects; Simvastatin; Troponin | 2006 |
Simvastatin may improve myocardial perfusion abnormality in slow coronary flow.
Topics: Adult; Angina Pectoris; Blood Chemical Analysis; Blood Flow Velocity; Chest Pain; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Middle Aged; Probability; Prospective Studies; Risk Assessment; Simvastatin; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2008 |
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Bisoprolol; Coronary Angiography; Coronary Vessel Anomalies; Coronary Vessels; Female; Humans; Magnetic Resonance Angiography; Middle Aged; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Simvastatin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Treatment of myocardial infarction and angina. Advice on reducing cholesterol should be included.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Humans; Lovastatin; Myocardial Infarction; Simvastatin | 1995 |
[The cholesterol hypothesis has been proved true at last].
Topics: Adult; Aged; Angina Pectoris; Anticholesteremic Agents; Cholesterol; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Myocardial Infarction; Simvastatin | 1995 |
Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Hyperlipidemias; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Scandinavian and Nordic Countries; Simvastatin | 1998 |
[Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
Topics: Adult; Age Factors; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Arcus Senilis; Cholesterol, HDL; Cholesterol, LDL; Diagnosis, Differential; Diet, Fat-Restricted; Female; Humans; Hyperlipoproteinemia Type II; Male; Myocardial Infarction; Simvastatin | 2000 |